4 Host, 96T, apoptosis, array, Assay, Bacteria Pig Pigeon, Bafilomycin A1, Deoxycholic Acid Sodium Salt, Glycodeoxycholic Acid, GMO, Green, Pamabrom 100Mg, Pepstatin A, Phospho 4Ebp1, Plant, Plate, Tubastatin A, Valproic Acid Sodium Salt
Isotope fractionation (δ 13 C, δ 15 N) and microbial community response in degradation of petroleum hydrocarbons
This examine investigated the isotope results of δ13C and δ15N and microbial response throughout biodegradation of hydrocarbons by biostimulation with nitrate or compost within the petroleum-contaminated soil. Compost and KNO3 amendments promoted the whole petroleum hydrocarbon (TPH) elimination accompanied by a big enhance of Actinobacteria and Firmicutes phyla. Soil alpha range decreased after 90 days of biostimulation. An inverse vital carbon isotope impact (εc = 16.6 ± 0.8‰) and sturdy vital nitrogen isotope impact (εN = -24.20 ± 9.54‰) had been proven by the KNO3 supplementation.
For compost modification, vital carbon and nitrogen isotope impact had been εc = 38.8 ± 1.1‰ and εN = -79.49 ± 16.41‰, respectively. A transparent distinction of the carbon and nitrogen steady isotope fractionation was evident by KNO3 or compost modification, which indicated that the mechanisms of petroleum degradation by including compost or KNO3 could also be completely different.
Compound-specific carbon isotope evaluation of unstable natural compounds in complicated soil extracts utilizing purge and entice focus coupled to heart-cutting two-dimensional gasoline chromatography-isotope ratio mass spectrometry
Compound-specific carbon isotope evaluation (CSIA) is a strong instrument to trace the origin and destiny of natural subsurface contaminants together with petroleum and chlorinated hydrocarbons and is often utilized to water samples. Nonetheless, soil can kind a big contaminant reservoir. In soil samples, it may be difficult to get well adequate quantities of unstable natural compounds (VOC) to carry out CSIA. Soil samples usually include complicated contaminant mixtures and gasoline chromatography combustion isotope ratio mass spectrometry (GC-C-IRMS) is very depending on good chromatographic separation as a result of conversion to a single analyte.
To increase the applicability of CSIA to complicated unstable natural compound mixtures in soil samples, and to get well adequate quantities of goal compounds for carbon CSIA, we in contrast two soil extraction solvents, tetraglyme (TGDE) and methanol, and developed a heart-cutting two-dimensional GC-GC-C-IRMS technique. We used purge & entice focus of solvent-water mixtures to extend the quantity of analyte delivered to the column and thus decrease technique detection limits. We optimized purge & entice and chromatographic parameters for twelve goal compounds, together with one affected by poor purge effectivity.
Through the use of a 30 m thick-film non-polar column within the first and a 15 m polar column within the second dimension, we achieved good chromatographic separation for the goal compounds in troublesome matrices and excessive accuracy (trueness and precision) for carbon isotopic evaluation. Tetraglyme extraction was proven to supply benefits over methanol for purge & entice focus, resulting in decrease goal compound technique detection limits for CSIA of soil samples.
The applicability of the developed technique was demonstrated for a case examine on soil extracts from a former manufacturing facility. Our strategy extends the applicability of CSIA to an necessary matrix that always controls the long-term destiny of contaminants within the subsurface.
Growth of Secure Isotope Dilution Assays for the Evaluation of Pure Types of Vitamin B12 in Meat
The primary a number of steady isotope dilution assay technique was developed for the simultaneous willpower of 4 cobalamins, particularly, hydroxocobalamin (OHCbl), adenosylcobalamin (AdoCbl), methylcobalamin (MeCbl), and cyanocobalamin (CNCbl), of their native kinds. The pattern preparation was optimized with enzyme therapy and immunoaffinity purification.
The evaluation was carried out by LC-MS/MS utilizing respective 15N-labeled cobalamins as inside requirements. Methodology validation resulted in limits of detection starting from 0.19 to 0.58 ng/g and limits of quantification starting from 0.68 to 1.73 ng/g. Recoveries at three ranges had been between 82 and 121%. Intra-day and inter-day precisions had been beneath 6% and 11% RSD, respectively.
The evaluation of a reference materials resulted in a variance of <1% from the licensed worth. The newly developed technique demonstrated wonderful sensitivity, restoration, accuracy, and reproducibility and was additional utilized to quantitate the 4 cobalamins in varied meats.
Boron Isotope Evaluation Reveals Borate Selectivity in Seaweeds
The function of boron in terrestrial plant physiology is numerous and more and more nicely understood, however its function in marine aquatic eukaryotes is much less clear. Our analysis reveals a particular and huge offset in boron isotopes from seawater, no matter seaweed kind or season. We present that the offset is according to the incorporation of borate from seawater. Boron is a recognized micronutrient in vegetation however only a few research have used boron isotopes to research boron’s function in plant physiology.
Seaweed, as essentially the most primitive multicellular plant, has an necessary function in investigating wider plant diversifications that use boron to fulfill purposeful wants. Moreover, seaweed and different vegetation are a key base nutrient supplier in meals webs, supplying boron to customers and enjoying a essential function in boron environmental biking.
The Intermolecular NOE Will depend on Isotope Choice: Brief Vary vs Lengthy Vary Conduct
The nuclear Overhauser impact (NOE) is a strong instrument in molecular construction elucidation, combining the refined chemical shift of NMR and three-dimensional data impartial of chemical connectivity. Its utilization for intermolecular research, nevertheless, is essentially restricted by an unspecific long-ranged interplay habits.
This joint experimental and computational work reveals that correct collection of interacting isotopes can overcome these limitations: Isotopes with strongly differing gyromagnetic ratios give rise to short-ranged intermolecular NOEs. On this mild, current NOE experiments have to be re-evaluated and future ones might be designed accordingly. Thus, a brand new chapter on intermolecular construction elucidation is opened.
Comparability of isotope ratio mass spectrometry and cavity ring-down spectroscopy procedures and precision of the doubly labeled water technique in several physiological specimens
Rationale: This examine determines if saliva assortment procedures for the doubly labeled water (DLW) technique, used for measuring complete vitality expenditure (TEE), are akin to urine and plasma assortment. Each the cavity ring-down spectroscopy (CRDS) and isotope ratio mass spectrometry (IRMS) evaluation strategies are in contrast.
Strategies: Saliva specimens had been collected from contributors for the DLW technique. Specimens had been collected below completely different situations; after consumption of faucet water, after chewing gum, and through publicity to situations of excessive and low relative humidity. The isotopes in saliva had been in contrast with simultaneous plasma and urine assortment. TEE calculated from saliva and analyzed by CRDS was in comparison with that of plasma analyzed by IRMS.
Outcomes: The within-individual variances weren’t considerably completely different between the saliva specimens(0.4‰) and plasma(0.3‰). Following the oral dose of DLW, the saliva specimens displayed a shorter equilibration time to urine. When contributors consumed 500mL of faucet water, the enrichment of saliva specimens reached a brand new plateau worth sooner than urine. Saliva assortment uncovered to excessive ambient humidity situations was barely much less enriched as in comparison with low humidity situations whereas urine enrichment was unaffected.
In distinction, whereas the within-individual results of gum chewing throughout saliva assortment on 18 O had been unaffected, the abundance of 2 H in saliva was barely decrease after chewing the gum. The within-individual distinction between TEE calculated from saliva versus calculated from plasma analyzed by IRMS didn’t differ from zero, and the SD was not completely different from that predicted by a propagation of error evaluation based mostly on analytical error alone.
Conclusions: Our findings help utilizing saliva specimens for the DLW technique. Evaluation of plasma and urine, nevertheless, require lowering the reminiscence impact arising from contaminants. Additionally, it ought to be carried out in a fashion that minimizes publicity to air the place specimens could also be uncovered to evaporation or contamination from water vapor throughout sampling.
 AAV2-GFP Control Virus |
|||
| AAV-302 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: GFP control virus of AAV serotype 2. |
|||
 AAV3-GFP Control Virus |
|||
| AAV-303 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: GFP control virus of AAV serotype 3. |
|||
 AAV4-GFP Control Virus |
|||
| AAV-304 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: GFP control virus of AAV serotype 4. |
|||
 AAV5-GFP Control Virus |
|||
| AAV-305 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: GFP control virus of AAV serotype 5. |
|||
 AAV6-GFP Control Virus |
|||
| AAV-306 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: GFP control virus of AAV serotype 6. |
|||
 scAAV1-GFP Control Virus |
|||
| AAV-331 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Self-complementary GFP control virus of AAV serotype 1. |
|||
 scAAV2-GFP Control Virus |
|||
| AAV-332 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Self-complementary GFP control virus of AAV serotype 2. |
|||
 scAAV3-GFP Control Virus |
|||
| AAV-333 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Self-complementary GFP control virus of AAV serotype 3. |
|||
 scAAV4-GFP Control Virus |
|||
| AAV-334 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Self-complementary GFP control virus of AAV serotype 4. |
|||
 scAAV5-GFP Control Virus |
|||
| AAV-335 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Self-complementary GFP control virus of AAV serotype 5. |
|||
 scAAV6-GFP Control Virus |
|||
| AAV-336 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Self-complementary GFP control virus of AAV serotype 6. |
|||
 Positive control tissue section for each antibody; Based on availability INQUIRE |
|||
| Control-Slides | Innovex | Set of 5 | EUR 211.2 |
 AAV1 antibody |
|||
| 10R-2473 | Fitzgerald | 5 mL | EUR 550.8 |
|
Description: Mouse monoclonal AAV1 antibody |
|||
 AAV1 ZsGreen |
|||
| 78443 | BPS Bioscience | 50 µl x 2 | EUR 545 |
|
Description: Adeno-Associated Virus Serotype 1 (AAV1) exhibits high homology with other AAV serotypes. AAV1 efficiently transduces muscle tissue, as determined by a region of the capsid protein VP1 (amino acids 350 to 430) which functions as a major determinant of tissue tropism._x000D_These AAV1 particles constitutively express ZsGreen under a CMV promoter. ZsGreen is a human codon-optimized variant of the green fluorescent protein isolated from reef coral (Zoanthus sp). It has been engineered for higher expression in mammalian cells and is up to four times brighter than enhanced GFP (eGFP). ZsGreen expression and AAV1 transduction efficiency can easily be verified and optimized by fluorescence microscopy or flow cytometry. ZsGreen has an excitation wavelength of 493 nm and an emission wavelength of 505 nm. |
|||
 AAV1 Luciferase |
|||
| 78452 | BPS Bioscience | 50 µl x 2 | EUR 545 |
|
Description: Adeno-Associated Virus Serotype 1 (AAV1) exhibits high homology with other AAV serotypes. AAV1 efficiently transduces muscle tissue, as determined by a region of the capsid protein VP1 (amino acids 350 to 430) which functions as a major determinant of tissue tropism._x000D_These AAV particles constitutively express the firefly (Photinus pyralis) luciferase under the control of a CMV promoter. |
|||
 AAV1 SaCas9 |
|||
| 78479 | BPS Bioscience | 50 µl x 2 | EUR 545 |
|
Description: Adeno-Associated Virus Serotype 1 (AAV1) exhibits high homology with other AAV serotypes. AAV1 efficiently transduces muscle tissue, as determined by a region of the capsid protein VP1 (amino acids 350 to 430) which functions as a major determinant of tissue tropism._x000D_Cas9 is an endonuclease enzyme that introduces a double stranded break into the DNA when recruited to a specific DNA sequence by the sgRNA (single guide RNA). This double stranded break is repaired in mammalian cells either through Non-Homologous End Joining or Homologous Recombination. Non-Homologous End Joining often results in the deletion or insertion of several base pairs at the cut site, which, when resulting in a frameshift, causes the functional inactivation of the gene._x000D_SaCas9 (Staphylococcus aureus CRISPR-associated protein 9) has demonstrated high cutting efficiency in mammalian cells, and its smaller size makes it ideal for packaging into AAV. SaCas9 recognizes a longer protospacer adjacent motif (PAM) site, 5'-NNGRRT-3', than the more traditional SpCas9 (Streptococcus pyogenes CRISPR-associated protein 9). These AAV particles constitutively express SaCas9 under the control of a CMV promoter. |
|||
 AAV1 ELISA Kit |
|||
| 55R-PROPRAAV1 | Fitzgerald | 96 tests | EUR 1406.4 |
|
Description: ELISA kit for detection of AAV1 in the research laboratory |
|||
 AAV1 Luciferase-eGFP |
|||
| 78461 | BPS Bioscience | 50 µl x 2 | EUR 545 |
|
Description: Adeno-Associated Virus Serotype 1 (AAV1) exhibits high homology with other AAV serotypes. AAV1 efficiently transduces muscle tissue, as determined by a region of the capsid protein VP1 (amino acids 350 to 430) which functions as a major determinant of tissue tropism._x000D_These AAV1 particles constitutively express the firefly (Photinus pyralis) luciferase and eGFP genes connected via a T2A linker, under the control of a CMV promoter. The T2A self-cleaving peptide (derived from Thosea asigna virus 2A) leads to the efficient cleavage of the transcript, and expression of luciferase and eGFP as two separate proteins. |
|||
 AAV1 Luciferase-mCherry |
|||
| 78470 | BPS Bioscience | 50 µl x 2 | EUR 545 |
|
Description: Adeno-Associated Virus serotype 1 (AAV1) exhibits high homology with other AAV serotypes. AAV1 efficiently transduces muscle tissue, as determined by a region of the capsid protein VP1 (amino acids 350 to 430) which functions as a major determinant of tissue tropism._x000D_These AAV particles constitutively express the firefly (Photinus pyralis) luciferase and mCherry genes connected via a T2A linker, under the control of a CMV promoter. The T2A self-cleaving peptide (derived from Thosea asigna virus 2A) leads to the efficient cleavage of the transcript, and expression of luciferase and mCherry as two separate proteins. |
|||
 AAV2-Cre Control Virus |
|||
| AAV-310 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Cre control virus of AAV serotype 2. |
|||
 AAV3-Cre Control Virus |
|||
| AAV-313 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Cre control virus of AAV serotype 3. |
|||
 AAV4-Cre Control Virus |
|||
| AAV-314 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Cre control virus of AAV serotype 4. |
|||
 AAV5-Cre Control Virus |
|||
| AAV-315 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Cre control virus of AAV serotype 5. |
|||
 AAV6-Cre Control Virus |
|||
| AAV-316 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Cre control virus of AAV serotype 6. |
|||
 AAV2-Luc Control Virus |
|||
| AAV-320 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Luciferase control virus of AAV serotype 2. |
|||
 AAV3-Luc Control Virus |
|||
| AAV-323 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Luciferase control virus of AAV serotype 3. |
|||
 AAV4-Luc Control Virus |
|||
| AAV-324 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Luciferase control virus of AAV serotype 4. |
|||
 AAV5-Luc Control Virus |
|||
| AAV-325 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Luciferase control virus of AAV serotype 5. |
|||
 AAV6-Luc Control Virus |
|||
| AAV-326 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Luciferase control virus of AAV serotype 6. |
|||
 AAV2-LacZ Control Virus |
|||
| AAV-342 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: LacZ control virus of AAV serotype 2. |
|||
 AAV3-LacZ Control Virus |
|||
| AAV-343 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: LacZ control virus of AAV serotype 3. |
|||
 AAV4-LacZ Control Virus |
|||
| AAV-344 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: LacZ control virus of AAV serotype 4. |
|||
 AAV5-LacZ Control Virus |
|||
| AAV-345 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: LacZ control virus of AAV serotype 5. |
|||
 AAV6-LacZ Control Virus |
|||
| AAV-346 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: LacZ control virus of AAV serotype 6. |
|||
 AAV2 Null Control Virus |
|||
| AAV-352 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Null (empty) control virus of AAV serotype 2. |
|||
 AAV3 Null Control Virus |
|||
| AAV-353 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Null (empty) control virus of AAV serotype 3. |
|||
 AAV4 Null Control Virus |
|||
| AAV-354 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Null (empty) control virus of AAV serotype 4. |
|||
 AAV5 Null Control Virus |
|||
| AAV-355 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Null (empty) control virus of AAV serotype 5. |
|||
 AAV6 Null Control Virus |
|||
| AAV-356 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Null (empty) control virus of AAV serotype 6. |
|||
 GFP Expressing Human Glioblastoma Cells |
|||
| TR01-GFP | Neuromics | 500,000 Cells | EUR 1624.8 |
 antibody) AAV1 (intact particle) antibody |
|||
| 10R-2446 | Fitzgerald | 50 ug | EUR 699.6 |
|
Description: Mouse monoclonal AAV 1 (intact particle) antibody |
|||
) pCDH-Cuo-RFP-T2A-GFP (positive control virus) |
|||
| QM350VA-1 | SBI | >1 x 10^6 IFUs | EUR 763.2 |
 GFP Expressing Human Gastric Carcinoma N87 Cells |
|||
| TR02-GFP | Neuromics | 500,000 Cells | EUR 1624.8 |
) GFP Expressing Human Renal Adenocarcinoma Cells (ACHN) |
|||
| TR04-GFP | Neuromics | 500,000 Cells | EUR 1624.8 |
) GFP Expressing Human Prostate Carcinoma Cells (DU 145) |
|||
| TR03-GFP | Neuromics | 500,000 Cells | EUR 1624.8 |
 pRedZeo-CMV Virus [positive control] |
|||
| SR10046VA-1 | SBI | >2 x 10^6 IFUs | EUR 826.8 |
 pRedTK-CMV Virus [positive control] |
|||
| SR10052VA-1 | SBI | >2 x 10^6 IFUs | EUR 826.8 |
 pGreenZeo-mCMV Virus [negative control] |
|||
| SR500VA-1 | SBI | >2 x 10^6 IFUs | EUR 806.4 |
 pGreenZeo-CMV Virus [positive control] |
|||
| SR501VA-1 | SBI | >2 x 10^6 IFUs | EUR 806.4 |
 Positive control tissue section for each individua |
|||
| Control-Slides-for-each-antibody | Innovex | Set of 25 | EUR 355 |
|
Description: Positive control tissue section for each individual antibody; Based on availability; INQUIRE |
|||
 GFP Lentivirus Control |
|||
| LTV-300 | Cell Biolabs | 1 vial | EUR 679.2 |
|
Description: HIV-1 Lentivirus |
|||
) Vaccinia virus Complement control protein C3 (VACWR025) |
|||
| 1-CSB-YP302389VAI | Cusabio |
|
|
|
Description: Recombinant Vaccinia virus Complement control protein C3(VACWR025) expressed in Yeast |
|||
 Influenza A virus HA Control/blocking peptide |
|||
| AB-23091-P | Alpha Diagnostics | 100ug | EUR 196.8 |
 ELISA Kit, 96 tests, Quantitative) Green Fluorescent Protein (GFP-fusion protein) ELISA Kit, 96 tests, Quantitative |
|||
| 800-420-GFP | Alpha Diagnostics | 1 kit | EUR 854.4 |
 Baboon Anti-Rabies Virus IgG antiserum negative control |
|||
| 600-070-03N | Alpha Diagnostics | 1 ml | EUR 196.8 |
 Baboon Anti-Rabies Virus IgG antiserum positive control |
|||
| 600-070-04P | Alpha Diagnostics | 1 ml | EUR 270 |
 Purified Nipah virus Glycoprotein control for Western Blotting |
|||
| NIV11-C | Alpha Diagnostics | 100 ul | EUR 343.2 |
 Purified Nipah virus Nucleoprotein control for Western Blotting |
|||
| NIV21-C | Alpha Diagnostics | 100 ul | EUR 270 |
 pAAV-GFP Control Vector |
|||
| AAV-400 | Cell Biolabs | 10 µg | EUR 679.2 |
|
Description: Use this control vector to co-transfect along with AAV packaging vectors to produce a recombinant AAV control. |
|||
 pscAAV-GFP Control Vector |
|||
| AAV-410 | Cell Biolabs | 10 µg | EUR 679.2 |
|
Description: Use this control vector to co-transfect along with AAV packaging vectors to produce a recombinant AAV control. |
|||
 GFP-Control Protein Vector |
|||
| PV003 | ABM | 500 ng | EUR 224.4 |
) pGreenFire 2.0-CMV positive control virus (pGF2-CMV-rFluc-T2A-GFP-mPGK-Puro) |
|||
| TR410VA-P | SBI | >2 x 10^6 IFUs | EUR 836.4 |
) pGreenFire 2.0-mCMV negative control virus (pGF2-mCMV-rFluc-T2A-GFP-mPGK-Puro) |
|||
| TR411VA-P | SBI | >2 x 10^6 IFUs | EUR 836.4 |
 Camelpox virus H3L/p35 protein control for western blot |
|||
| CPOX11-C | Alpha Diagnostics | 100 ul | EUR 343.2 |
 Rhesus Monkey Anti-Rabies Virus IgG antiserum negative control |
|||
| 600-070-01N | Alpha Diagnostics | 1 ml | EUR 196.8 |
 Rhesus Monkey Anti-Rabies Virus IgG antiserum positive control |
|||
| 600-070-02P | Alpha Diagnostics | 1 ml | EUR 270 |
 Anti-Rabies Virus IgG antiserum negative control) Monkey (Cynomolgous) Anti-Rabies Virus IgG antiserum negative control |
|||
| 600-070-05N | Alpha Diagnostics | 1 ml | EUR 196.8 |
 Cynos Monkey Anti-Rabies Virus IgG antiserum positive control |
|||
| 600-070-06P | Alpha Diagnostics | 1 ml | EUR 270 |
 IgG negative control serum) Human Anti-Mumps Virus (parotitis) IgG negative control serum |
|||
| 520-100-01N | Alpha Diagnostics | 1 ml | EUR 196.8 |
 IgG positive control serum) Human Anti-Mumps Virus (parotitis) IgG positive control serum |
|||
| 520-100-02P | Alpha Diagnostics | 1 ml | EUR 270 |
 IgG negative control serum) Mouse Anti-Mumps Virus (parotitis) IgG negative control serum |
|||
| 520-130-05N | Alpha Diagnostics | 1 ml | EUR 196.8 |
 IgG positive control serum) Mouse Anti-Mumps Virus (parotitis) IgG positive control serum |
|||
| 520-130-06P | Alpha Diagnostics | 1 ml | EUR 270 |
 IgG negative control serum) Monkey Anti-Mumps Virus (parotitis) IgG negative control serum |
|||
| 520-160-03N | Alpha Diagnostics | 1 ml | EUR 196.8 |
 IgG positive control serum) Monkey Anti-Mumps Virus (parotitis) IgG positive control serum |
|||
| 520-160-04P | Alpha Diagnostics | 1 ml | EUR 270 |
 Capsid Protein control for Western Blotting) Mayaro virus (MAYV) Capsid Protein control for Western Blotting |
|||
| MAYV31-C | Alpha Diagnostics | 100 ul | EUR 343.2 |
 nsP1 protein control for Western Blotting) Mayaro virus (MAYV) nsP1 protein control for Western Blotting |
|||
| MAYV41-C | Alpha Diagnostics | 100 ul | EUR 343.2 |
 6K Protein control for Western Blotting) Mayaro virus (MAYV) 6K Protein control for Western Blotting |
|||
| MAYV51-C | Alpha Diagnostics | 100 ug | EUR 343.2 |
 E3 protein control for Western Blotting) Mayaro virus (MAYV) E3 protein control for Western Blotting |
|||
| MAYV61-C | Alpha Diagnostics | 100 ul | EUR 343.2 |
) pGreenPuro Scramble Hairpin Control - Virus (for shRNAs and miRZips) |
|||
| MZIP000-VA-1 | SBI | >1 x 10^6 IFUs | EUR 859.2 |
 Control/Blocking peptide for Tobacco Mosaic Virus Movement Protein |
|||
| TMVMP11-P | Alpha Diagnostics | 100 ug | EUR 196.8 |
 control for Western blot) Zika Virus prM Protein (African) control for Western blot |
|||
| ZPRM11-C | Alpha Diagnostics | 100 ul | EUR 343.2 |
 Capsid Protein 1 (VP1) control for Western blot) Recombinant Polyoma Virus (KV, Pneumotropic virus) Capsid Protein 1 (VP1) control for Western blot |
|||
| KVP14-C | Alpha Diagnostics | 100 ul | EUR 343.2 |
 pLenti-GFP Lentiviral Control Vector |
|||
| LTV-400 | Cell Biolabs | 100 µL | EUR 741.6 |
|
Description: Use this control vector to co-transfect along with lentivirus packaging vectors to make a recombinant control lentivirus. |
|||
 GFP inducible control lentiviral particles |
|||
| LVP024 | GenTarget | 1x10e7 IFU/ml x 200ul | EUR 418.8 |
|
Description: Pre-made lentiviral particles expressing codon optimized GFP under tetracycline inducible suCMV promoter. Particles contain a blasticidin-RFP fusion dual marker under the constitutive RSV promoter. |
|||
) pMC.CMV-GFP-SV40PolyA (positive control) |
|||
| MN601A-1 | SBI | 10 ug | EUR 882 |
 pHT10- gfp +control VT Plasmid |
|||
| PVT5006 | Lifescience Market | 2 ug | EUR 390 |
 Camel Anti-Camelpox virus H3L/p35 IgG negative control serum |
|||
| AE-311170-01N | Alpha Diagnostics | 1 ml | EUR 196.8 |
 Camel Anti-Camelpox virus H3L/p35 IgG positive control serum |
|||
| AE-311170-02P | Alpha Diagnostics | 1 ml | EUR 270 |
 IgG antiserum negative control) Baboon Anti-Rabies Virus Glycoprotein (RVG) IgG antiserum negative control |
|||
| 600-180-01N | Alpha Diagnostics | 1 ml | EUR 196.8 |
 IgG antiserum positive control) Baboon Anti-Rabies Virus Glycoprotein (RVG) IgG antiserum positive control |
|||
| 600-180-02P | Alpha Diagnostics | 1 ml | EUR 270 |
 IgG Negative Control Serum) Human Anti-Respiratory syncytial virus (RSV) IgG Negative Control Serum |
|||
| 510-300-01N | Alpha Diagnostics | 1 ml | EUR 196.8 |
 IgG Negative Control Serum) Monkey Anti-Respiratory syncytial virus (RSV) IgG Negative Control Serum |
|||
| 510-325-01N | Alpha Diagnostics | 1 ml | EUR 196.8 |
 IgG Positive Control Serum) Monkey Anti-Respiratory syncytial virus (RSV) IgG Positive Control Serum |
|||
| 510-325-02P | Alpha Diagnostics | 1 ml | EUR 270 |
 IgG negative control serum) Mouse Anti-Respiratory syncytial virus (RSV) IgG negative control serum |
|||
| 510-345-01N | Alpha Diagnostics | 1 ml | EUR 196.8 |
 IgG positive control serum) Mouse Anti-Respiratory syncytial virus (RSV) IgG positive control serum |
|||
| 510-345-02P | Alpha Diagnostics | 1 ml | EUR 270 |
 P/V Control/blocking peptide) Simian virus 5 (starin W3) P/V Control/blocking peptide |
|||
| AB-23077-P | Alpha Diagnostics | 100ug | EUR 196.8 |
 matrix protein 2 Control/blocking peptide) Influenza A virus (H5N1) matrix protein 2 Control/blocking peptide |
|||
| M2E15-P | Alpha Diagnostics | 100 ug | EUR 196.8 |
 matrix protein 2 Control/blocking peptide) Influenza A virus (H1N1) matrix protein 2 Control/blocking peptide |
|||
| M2E16-P | Alpha Diagnostics | 100 ug | EUR 196.8 |
 matrix protein 2 Control/blocking peptide) Influenza A virus (H9N2) matrix protein 2 Control/blocking peptide |
|||
| M2E17-P | Alpha Diagnostics | 100 ug | EUR 196.8 |
